Closed
SectorHealthcare
44.13 -3.39
24h
Min
43.42
Max
46.33
Income | 5.2M -66M |
---|---|
Sales | 15M 22M |
EPS | -0.82 |
Profit margin | -296.747 |
Employees | 208 |
EBITDA | 5.3M -63M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +35.79% upside |
Next Earnings | 7 sie 2025 |
---|
Market Cap | 828M 3B |
---|---|
Previous open | 47.52 |
Previous close | 44.13 |
By Acuity
50%
50%
162 / 380 Ranking in Healthcare
By Trading Central
Confidence
Weak Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 62.07 USD 35.79%
High 79 USD
Low 51 USD
Based on 17 Wall Street analysts offering 12 month price targets forKymera Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$